After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold. The ...
India embraces GLP-1 medications as a major advance in diabetes and obesity care. At AajTak Health Summit, endocrinologist Dr. Ambrish Mithal and Vikrant Shrotriya, Vice President MD, Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback